Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
"RichSource" appears to refer to more than one health-related company, and the best current exact match is not a drug-development biotech. The clearest active operating entity using the name today is Shandong Richsource Biological Technology Co., Ltd., a China-based oral care manufacturer that provides OEM/ODM and private-label production of dental floss picks, interdental brushes, tongue scrapers, toothpicks, and related oral hygiene products. It markets itself as a high-tech enterprise focused on large-scale manufacturing, customization, and export rather than therapeutic drug R&D. A separate U.S. entity, RichSource Stem Cells, Inc., marketed perinatal tissue-derived products such as RICHGEN and received an FDA untitled letter in November 2019 concerning unapproved stem cell-related marketing claims. Because the requested name is ambiguous, this record prioritizes the currently active Shandong Richsource entity while noting the distinct U.S. stem-cell company in other fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RichSource.